FDA panel recommends rezafungin for Candida

FDA panel recommends rezafungin for Candida

The Food and Drug Administration (FDA) antimicrobial drugs advisory committee yesterday recommended the approval of rezafungin for the treatment of candidemia and invasive candidiasis in adults, the first new drug to treat the conditions in over a decade. Cidara...
Probiotic markedly reduces MRSA colonization

Probiotic markedly reduces MRSA colonization

MRSA bacteria bound to a neutrophil, a type of infection-fighting white blood cell. CREDIT: National Institute of Allergy and Infectious Diseases, National Institutes of Health A promising approach to control Staphylococcus aureus bacterial colonization in...
Wearable sensor could guide precision drug dosing

Wearable sensor could guide precision drug dosing

The sensor uses microneedles that are made by cutting down clinical-grade acupuncture needles. For some of the powerful drugs used to fight infection and cancer, there’s only a small difference between a healing dose and a dose that’s large enough to cause dangerous...
Encouraging findings in HIV vaccine approach

Encouraging findings in HIV vaccine approach

While scientists have struggled in the past to create an effective vaccine against HIV, a novel vaccine design strategy being pursued by researchers at Scripps Research, IAVI, Fred Hutchinson Cancer Center (Fred Hutch) and the National Institutes of Health, National...
NIH awards $12 million to develop antiviral therapies

NIH awards $12 million to develop antiviral therapies

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic...